Shopping Cart
- Remove All
- Your shopping cart is currently empty
Anticanceragent 241 (HZ1) is a novel orally active inhibitor specifically targeting cell cycle-dependent kinase-like 3 (CDKL3). It demonstrates potent antitumor effects and has the potential to overcome resistance to CDK4/6 inhibitors.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | Anticanceragent 241 (HZ1) is a novel orally active inhibitor specifically targeting cell cycle-dependent kinase-like 3 (CDKL3). It demonstrates potent antitumor effects and has the potential to overcome resistance to CDK4/6 inhibitors. |
In vitro | Anticancer agent 241 (HZ1; 100 nM) notably diminishes the levels of pRb and CDK4, effectively inducing cell cycle arrest and tumor cell death. |
In vivo | Anticancer agent 241 (HZ1; 1 mg/kg; oral gavage; daily for 12-14 days) exhibits anticancer activity in a mouse colon cancer model. |
Molecular Weight | 362.43 |
Formula | C20H22N6O |
Cas No. | 3030492-40-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.